Pirmitegravir
Pirmitegravir (STP0404) is a potent and selective inhibitor of allosteric integrase (ALLINI) targeting the LEDGF/p75 binding site. Pirmitegravir inhibits PBMC. Pirmitegravir inhibits PBMC.Pirmitegravir has significant antiviral activity and may be useful in the study of HIV virus infection.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
495.01
Molecular Formula
C27H31ClN4O3
Notes
Research use only, not for human use.
Receptor
HIV Protease
CAS Number
2245231-10-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6330519-01 0.2 mL
PAH, ID (PAH, Phenylalanine-4-hydroxylase, Phe-4-monooxygenase) (FITC)
Ask
View Details MBS6330519-02 5x 0.2 mL
PAH, ID (PAH, Phenylalanine-4-hydroxylase, Phe-4-monooxygenase) (FITC)
Ask
View Details 
